ArticlePloS one2021

Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease.

Sebastian Cremer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.